Medically reviewed by Ronald Lubelchek, MD HIV symptoms vary by the stage of infection, known as acute HIV infection (Stage 1), chronic HIV infection (Stage 2), and AIDS (Stage 3). During primary ...

A new case report now highlights the test's fallibility in late-stage AIDS. A 28-year-old man came to a Michigan emergency room repeatedly during a 9-month period.

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in adults receiving another form of therapy in two late-stage studies, the ...

Islatravir (MK-8591), Merck’s investigational drug, is being evaluated in multiple early and late-stage clinical trials in combination with other antiretroviral therapies for the treatment of HIV-1.

Just diagnosed with HIV? We have answers to your most commonly-asked questions, including what it means to be "undetectable." ...

The cancer drugmaker's clinical program for islatravir involves multiple early- and late-stage trials, including a Phase 3 trial called MK-8591A-053 for newly diagnosed HIV patients.

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Islatravir (MK-8591), Merck’s investigational drug, is being evaluated in multiple early and late-stage clinical trials in combination with other antiretroviral therapies for the treatment of HIV-1.